Cambridge Investment Research Advisors, Inc. - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 23 filers reported holding CNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
-28.6%
25,2500.0%0.00%
Q2 2022$7,000
-22.2%
25,2500.0%0.00%
Q1 2022$9,000
-50.0%
25,2500.0%0.00%
Q4 2021$18,000
+5.9%
25,250
+124.4%
0.00%
Q3 2021$17,000
-15.0%
11,250
+9.8%
0.00%
Q2 2021$20,00010,2500.00%
Other shareholders

There were no reported owners of CNS PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of CNS PHARMACEUTICALS INC shareholders